Thus, oncogenic mutations or inflammation mainly mediate PD-L1 expression by cancer cells [111,112], finally leading to tumor resistance [113] and promotion of tumor growth by means of antiapoptotic signals [114]. The gene discussed is CD274; the disease is cancer.